Deka Bank Deutsche Girozentrale Abb Vie Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Abb Vie Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 3,054,882 shares of ABBV stock, worth $536 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

3,054,882

Previous 3,208,256 4.78%

Holding current value

$536 Million

Previous $547 Million 9.16%

% of portfolio

1.11%

Previous 0.98%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $25.1 Million - $30.6 Million	-153,374 Reduced 4.78%	3,054,882 $597 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $19.2 Million - $22.5 Million	124,225 Added 4.03%	3,208,256 $547 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $15.1 Million - $17.2 Million	-94,223 Reduced 2.96%	3,084,031 $554 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $12.6 Million - $14.2 Million	91,359 Added 2.96%	3,178,254 $489 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $3.9 Million - $4.51 Million	-29,191 Reduced 0.94%	3,086,895 $472 Million
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $21.8 Million - $27.1 Million	164,263 Added 5.56%	3,116,086 $419 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $38.5 Million - $44.3 Million	-265,991 Reduced 8.27%	2,951,823 $463 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $47.1 Million - $56.5 Million	340,371 Added 11.83%	3,217,814 $522 Million
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $18.1 Million - $20.8 Million	135,166 Added 4.93%	2,877,443 $407 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $17.7 Million - $22.5 Million	128,379 Added 4.91%	2,742,277 $418 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $49.5 Million - $61.4 Million	-375,251 Reduced 12.55%	2,613,898 $429 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $12.6 Million - $16 Million	117,352 Added 4.09%	2,989,149 $407 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $11.8 Million - $13.4 Million	110,839 Added 4.01%	2,871,797 $314 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $23.8 Million - $26.5 Million	226,431 Added 8.93%	2,760,958 $310 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $26.9 Million - $29.6 Million	262,815 Added 11.57%	2,534,527 $271 Million
Q4 2020 Mar 12, 2021	BUY	$80.49 - $108.67 $36.5 Million - $49.2 Million	452,897 Added 24.9%	2,271,712 $239 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $66.7 Million - $78.3 Million	776,468 Added 74.49%	1,818,815 $159 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $7.95 Million - $10.6 Million	108,401 Added 11.61%	1,042,347 $101 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $1.22 Million - $1.86 Million	18,983 Added 2.07%	933,946 $70.3 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $1.37 Million - $1.72 Million	-19,014 Reduced 2.04%	914,963 $82.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.89 Million - $2.27 Million	29,985 Added 3.32%	933,977 $70.2 Million
Q2 2019 Aug 01, 2019	BUY	$65.7 - $83.98 $33.7 Million - $43.1 Million	513,424 Added 131.46%	903,992 $63.8 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $33 Million - $38.9 Million	-428,076 Reduced 52.29%	390,568 $38.3 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $33.3 Million - $41.1 Million	428,076 Added 109.6%	818,644 $74.1 Million
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $1.51 Million - $1.68 Million	17,020 Added 4.56%	390,568 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $2.77 Million - $3.28 Million	30,840 Added 9.0%	373,548 $35.1 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $5.79 Million - $7.75 Million	-62,891 Reduced 15.51%	342,708 $33 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $28.3 Million - $36.2 Million	405,599	405,599 $29 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Abb Vie Inc. Transaction History